Several molecular BC subtypes have been described from an immunohistochemical perspective and based on the involvement of specific hormone and growth factor receptors: luminal A, luminal B, HER2-enriched and triple-negative (TNBC or basal-like), as shown in Figure 1. This evidence concerns the gene ERBB2 and breast cancer.